Mary M Mader

5PUBLICATIONS
58CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsProteins and peptidesBiologically active moleculesClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 09, 2026
Nanoscale Direct-to-Biology Optimization of Cdk2 Inhibitors.

James L Douthwaite, Damian J Houde, Eneida Pardo

|Nov 02, 2023
Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3Kα Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia.

Andreas Varkaris, Ermira Pazolli, Hakan Gunaydin

|Sep 15, 2023
Which Small Molecule? Selecting Chemical Probes for Use in Cancer Research and Target Validation.

Mary M Mader, Joachim Rudolph, Ingo V Hartung

|Jul 05, 2023
Expanding Chemical Probe Space: Quality Criteria for Covalent and Degrader Probes.

Ingo V Hartung, Joachim Rudolph, Mary M Mader

|Mar 21, 2022
Principles of Kinase Allosteric Inhibition and Pocket Validation.

Yue Pan, Mary M Mader

Pageof 1

Frequent Collaborators

2 joint publications

Ingo V Hartung

2 joint publications

Joachim Rudolph

2 joint publications

Paul Workman

2 joint publications

Michael J Holliday